How Does Revolution Medicines Inc (RVMD) Stock Rank on Wall Street Tuesday?

Tuesday, April 05, 2022 02:09 PM | InvestorsObserver Analysts

Mentioned in this article

Wall Street is positive on Revolution Medicines Inc (RVMD). On average, analysts give RVMD a Strong Buy rating. The average price target is $32.5, which means analysts expect the stock to increase by 22.09% over the next twelve months. That average ranking earns RVMD an Analyst Rating of 53, which is better than 53% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating RVMD a Strong Buy today. Find out what this means to you and get the rest of the rankings on RVMD!
See Full RVMD Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Revolution Medicines Inc Stock Today?

Revolution Medicines Inc (RVMD) stock is trading at $26.62 as of 2:09 PM on Tuesday, Apr 5, a loss of -$0.55, or -2.02% from the previous closing price of $27.17. The stock has traded between $26.52 and $27.49 so far today. Volume today is 681,856 compared to average volume of 761,130. Click Here to get the full Stock Report for Revolution Medicines Inc stock.

Share this article:

Related Articles